Cancer immunoediting: from immunosurveillance to tumor escape
about
sameAs
Immunosignaturing can detect products from molecular markers in brain cancerClonal origin and evolution of a transmissible cancerThymic peptides for treatment of cancer patientsThe heat shock protein 90-CDC37 chaperone complex is required for signaling by types I and II interferonsTYK2 is a key regulator of the surveillance of B lymphoid tumorsCan tissue-based immune markers be used for studying the natural history of cancer?Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human gliomaCancer immunoediting from immune surveillance to immune escapeT cell responses against tumor associated antigens and prognosis in colorectal cancer patientsRevisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapyThe changes of CD4+CD25+/CD4+ proportion in spleen of tumor-bearing BALB/c miceScreening and identification of differentially expressed transcripts in circulating cells of prostate cancer patients using suppression subtractive hybridization.Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cellsTowards tumor immunodiagnosticsImmune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?Current and emerging therapies in unresectable and recurrent gastric cancerTargeting microRNAs as key modulators of tumor immune responseUveal melanoma as a target for immune-therapyTumor-intrinsic oncogene pathways mediating immune avoidanceTumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune TargetingBacteria in Cancer Therapy: Renaissance of an Old ConceptA Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in CancerImmune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumA primer on tumour immunology and prostate cancer immunotherapyBreast cancer survival among young women: a review of the role of modifiable lifestyle factorsImmunological interactions in radiotherapy-opening a new window of opportunityImmunological Landscape and Clinical Management of Rectal CancerPD-1/PD-L1 blockade in cancer treatment: perspectives and issuesMilky spots: omental functional units and hotbeds for peritoneal cancer metastasisAnti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic ApproachesTailoring the Treatment of Melanoma: Implications for Personalized MedicineNanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and ImmunotherapyCancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant StateCurcumin and tumor immune-editing: resurrecting the immune systemRelevance of tumor-infiltrating lymphocytes in breast cancerMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentUtilizing population variation, vaccination, and systems biology to study human immunologyTranslational implications of tumor heterogeneityAntigen presenting cell/ tumor cell fusion vaccines for cancer immunotherapyAcquired and intrinsic resistance in cancer immunotherapy
P2860
Q21134151-8442E794-2B77-40D3-902B-23E4DAEA2940Q22252319-2539F829-583E-4CF2-9A92-88EB42ABC37CQ24236667-B4A4805E-BF63-4685-903F-D383C17FA838Q24294462-1C68B18D-623D-4C86-AE7A-4CB69AF6BFF9Q24559982-34F06AA2-CA70-4421-8879-BF64A4F9781CQ24605537-CBFCAF91-BD48-4BBF-904D-B47E1880EE51Q24615166-FA1F1B33-2884-42B9-851D-0C947BA9150FQ24655415-D2FE1C0C-3A70-48AF-AA83-4A06ABB05E74Q24796257-2B27CB19-FDC6-456C-BD21-9EA670BF6551Q24805285-F59FE0CD-01A1-43F6-B9DF-EF42BC73FB81Q24805327-BE13B6B3-52A9-4CEC-AE9A-AA8102C88FBCQ24811648-C4E47E02-DE90-4354-B970-6037DA7B6BE1Q24813407-36208D98-9B3C-40BE-8407-AC17276C678CQ26738691-53AA6C28-B8CF-456B-A069-368112816CA4Q26740601-8A83A3F5-83B5-4026-B537-2D32970CC0F9Q26745453-1FD00CE2-4FC8-4FCC-8E1D-753A9DD48C74Q26746972-D9F965D6-C159-4830-975B-1650D3071EE2Q26747519-0461C0F6-BD30-429E-9EAD-D03EF3389ACBQ26747707-A9D74D46-04DC-4715-9AB3-5E2E21F62EA0Q26747792-09AF92A3-400B-498C-9160-BF05F5B235F7Q26751222-CBD660C6-DBED-4681-B23B-4E17AD6561DCQ26751472-35884CE5-DF73-4595-9B89-43F736CDC62AQ26765459-E013A164-28F6-43AD-8AE8-AD965F416961Q26765697-5B8449EB-C82F-4CDA-BFF1-662466E8F3CCQ26766205-7CDA7E60-49F8-4606-8861-96A54EDECC23Q26767178-B8A62086-165A-41D8-9E41-8D5B4EFA12BBQ26768531-A0FD24A1-8C74-4475-BDD0-B6BAEFD5C78FQ26768641-1BA6E745-1BD3-4EE8-9DF1-760C46820EAAQ26772888-E13B9336-FCC0-46F8-9FA1-12A816080D36Q26774312-BF888B12-B6FB-4837-AAB3-7403E8C6F186Q26775806-23143C42-130A-4467-90F6-02F4CEA824A3Q26782566-B9E9E9CF-EC35-4D89-9F40-C124716EB7AFQ26782573-BCCE93E3-DD1E-4645-AF28-5037DEB116ECQ26783491-80FD56FF-7486-4C04-8AC0-CEF565119730Q26795598-E1306831-2CC7-4FEC-8988-D8715054C58AQ26799126-915C785C-0D06-443E-9DF3-D3CCF14051C0Q26799374-8AEF54A8-6EDE-42C5-811D-1CDC8E2BA90CQ26822823-2F9D9CA6-CBC8-4F54-A38B-8F75EC51B846Q26824676-FE951E87-FAE0-482E-9FF9-D2980EC0ACDEQ26827701-C9A90F3A-5591-4E54-B0F7-DA9B7E97155B
P2860
Cancer immunoediting: from immunosurveillance to tumor escape
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cancer immunoediting: from immunosurveillance to tumor escape
@ast
Cancer immunoediting: from immunosurveillance to tumor escape
@en
Cancer immunoediting: from immunosurveillance to tumor escape
@nl
type
label
Cancer immunoediting: from immunosurveillance to tumor escape
@ast
Cancer immunoediting: from immunosurveillance to tumor escape
@en
Cancer immunoediting: from immunosurveillance to tumor escape
@nl
prefLabel
Cancer immunoediting: from immunosurveillance to tumor escape
@ast
Cancer immunoediting: from immunosurveillance to tumor escape
@en
Cancer immunoediting: from immunosurveillance to tumor escape
@nl
P2093
P3181
P356
P1433
P1476
Cancer immunoediting: from immunosurveillance to tumor escape
@en
P2093
Allen T Bruce
Gavin P Dunn
Hiroaki Ikeda
Lloyd J Old
Robert D Schreiber
P2888
P3181
P356
10.1038/NI1102-991
P407
P577
2002-11-01T00:00:00Z
P5875
P6179
1013709887